Zhengrong Shuai

Title: Zhengrong Shuai: Innovator in Antibody Development

Introduction

Zhengrong Shuai is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 2 patents, his work focuses on innovative solutions for treating various diseases.

Latest Patents

Zhengrong Shuai's latest patents include groundbreaking research on Anti-PD-1 antibodies and Anti-PD-L1 antibodies. The Anti-PD-1 antibodies patent describes the antibodies and their antigen-binding fragments, along with nucleic acids encoding these antibodies. It also outlines compositions that include the antibodies and methods for producing them. These antibodies are intended for treating or preventing diseases such as cancers and autoimmune diseases. The Anti-PD-L1 antibodies patent similarly provides details on the antibodies and their fragments, nucleic acids, and methods for their production and use in treating cancer, infectious diseases, and autoimmune diseases.

Career Highlights

Throughout his career, Zhengrong Shuai has worked with notable companies such as Shanghai Yunyi Healthcare and Technology Co., Ltd. and Jiangsu Hyamab Pharmaceutical Co., Ltd. His expertise in antibody development has positioned him as a key figure in the biotechnology sector.

Collaborations

Zhengrong Shuai has collaborated with talented individuals in his field, including Lile Liu and Xinxiu Yang. These partnerships have contributed to the advancement of his research and the successful development of innovative therapies.

Conclusion

Zhengrong Shuai's contributions to antibody research and development highlight his role as an influential inventor in the biotechnology industry. His patents reflect a commitment to addressing critical health challenges through innovative solutions.